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Abstract. 
 
L1 is a multidomain transmembrane neural 
recognition molecule essential for neurohistogenesis. 
While moieties in the immunoglobulin-like domains of 
L1 have been implicated in both heterophilic and ho-
mophilic binding, the function of the ﬁbronectin
(FN)-like repeats remains largely unresolved. Here, we 
demonstrate that the third FN-like repeat of L1 (FN3) 
spontaneously homomultimerizes to form trimeric and 
higher order complexes. Remarkably, these complexes 
support direct RGD-independent interactions with
several integrins, including 
 
a
 
v
 
b
 
3
 
 and 
 
a
 
5
 
b
 
1
 
. A pep-
tide derived from the putative C-C
 
9
 
 loop of FN3 
(GSQRKHSKRHIHKDHV
 
852
 
) also forms trimeric 
complexes and supports 
 
a
 
v
 
b
 
3 
 
and 
 
a
 
5
 
b
 
1
 
 binding. Substi-
tution of the dibasic RK
 
841
 
 and KR
 
845
 
 sequences within 
this peptide or the FN3 domain limited multimerization 
and abrogated integrin binding. Evidence is presented 
that the multimerization of, and integrin binding to, the 
FN3 domain is regulated both by conformational con-
straints imposed by other domains and by plasmin-
 
mediated cleavage within the sequence RK
 
¯
 
HSK
 
¯
 
RH
 
846
 
. 
The integrin 
 
a
 
9
 
b
 
1
 
, which also recognizes the FN3 do-
main, colocalizes with L1 in a manner restricted to sites 
of cell–cell contact. We propose that distal receptor li-
gation events at the cell–cell interface may induce a 
conformational change within the L1 ectodomain that 
culminates in receptor multimerization and integrin re-
cruitment via interaction with the FN3 domain.
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anoma • 
 
a
 
v
 
b
 
3 
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Introduction
 
Human L1 is a member of a subfamily of phylogenetically
conserved neural recognition molecules that share a com-
plex ectodomain structure consisting of multiple immuno-
globulin and fibronectin (FN)
 
1 
 
type III repeats (Hortsch,
1996). Orthologues of human and mouse L1 have been de-
scribed, including NILE (rat), NgCAM (chick), E587
(goldfish), L1.1/L1.2 (zebrafish), and neuroglian (
 
Dro-
sophila
 
) (Bock et al., 1985; Lemmon and McLoon, 1986;
Bieber et al., 1989; Bastmeyer et al., 1995; Tongiorgi et al.,
1995). Pioneering studies implicated the L1 subfamily in a
variety of dynamic neurological processes, including neu-
rite fasciculation and outgrowth, as well as cerebellar cell
migration (Lindner et al., 1983; Martini and Schachner,
1986; Lagenaur and Lemmon, 1987). With the recent gen-
eration of L1-deficient mice, it has been confirmed that L1
is required for normal corticospinal axon guidance (Cohen
et al., 1997) and for axonal ensheathment by nonmyelinat-
ing Schwann cells (Dahme et al., 1997; Haney et al., 1999).
Many of the neuropathologies now described in L1 knock-
out mice, including dilated brain ventricles, abnormal den-
dritic architecture, and developmental defects in the hip-
pocampus and corpus callosum (Dahme et al., 1997;
Demyanenko et al., 1999), are consistent with the manifes-
tations of CRASH, a neurological syndrome associated
with mutations in the human L1 gene (Fransen et al., 1997;
Brummendorf et al., 1998).
Although designated a neural cell adhesion molecule
(CAM), both murine and human L1 homologues have
been described on cells of diverse histological origin in-
cluding epithelial cells associated with kidney collecting
ducts (Debiec et al., 1998) and with the intestinal and uro-
genital tract (Thor et al., 1987; Kujat et al., 1995). Interest-
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ingly, the L1 expressed by renal epithelium has been
shown to be important for normal branching morphogene-
sis (Debiec et al., 1998). Cells of lymphoid and my-
elomonocytic origin also express L1 (Ebeling et al., 1996;
Pancook et al., 1997), however, the functional significance
of L1 within the immune system remains to be deter-
mined. In this regard, Di Sciullo et al. (1998) have shown
that L1 is important for maintaining normal lymph node
architecture during an immune response and suggest a
mechanism based on the expression of L1 by reticular fi-
broblasts. A potential function for L1 in tumor progres-
sion is also suggested by widespread expression on many
tumor cell lines including neuroectodermal tumors (mela-
noma and neuroblastoma), carcinomas (lung, renal, and
skin), and monocytic leukemias (Mujoo et al., 1986; Linne-
mann et al., 1989; Reid and Hemperly, 1992; Katayama et al.,
1997; Pancook et al., 1997). Supporting a role for L1 in tu-
mor progression, Linnemann et al. (1989) reported finding
elevated levels of L1 on a metastatic variant of a mela-
noma cell line. Indeed, a recent study by Ohnishi et al.
(1998) suggests that L1 may promote metastasis by facili-
tating tumor cell invasion or migration.
Structure–function studies have defined multiple inter-
active moieties within L1 that facilitate either homophilic
or heterophilic interactions (Hortsch, 1996). Thus far,
many of the interactions defined involve one or more of the
six Ig-like domains that constitute the NH
 
2
 
-terminal por-
tion of the L1 ectodomain. An antiparallel alignment of
the first four Ig-like domains of L1 is proposed to facilitate
homophilic L1–L1 binding (Su et al., 1998). The chon-
droitin sulfate proteoglycan, neurocan, binds with high
affinity to the NH
 
2
 
-terminal Ig-like domain of L1 (Oles-
zewski et al., 1999). An arginine-glycine-aspartate (RGD)
motif in the sixth Ig-like domain of human L1 supports
heterophilic interactions with multiple members of the in-
tegrin superfamily, including 
 
a
 
v
 
b
 
3 
 
and 
 
a
 
5
 
b
 
1 
 
(Montgomery
et al., 1996; Felding-Habermann et al., 1997; Oleszewski et
al., 1999). Axonin-1/TAG-1, a neuron-specific CAM, un-
dergoes a cis-interaction with the chick L1-orthologue
NgCAM via multiple moieties including the first and sec-
ond Ig-like domains as well as the third FN-like repeat
(Kunz et al., 1998). Other cis-interacting elements include
the tetraspan signaling molecule CD9 (Schmidt et al.,
1996), NCAM (Feizi, 1994), and the heat-stable antigen
CD24 (Kadmon et al., 1995), although the regions of L1 re-
sponsible for these interactions have yet to be determined.
The functional significance of the FN-like repeats that
constitute the membrane-proximal portion of the L1
ectodomain remains largely unresolved. An antibody di-
rected to an epitope between FN-like repeats 2 and 3 has
been shown to promote signal transduction and concomi-
tant neurite extension (Appel et al., 1995). Based on this
observation the authors proposed that distal recognition
events may induce conformational changes that are fun-
neled to a region within the FN-like repeats, which then
represents the ultimate site for the induction of signaling
events. Recent rotary shadow analysis of the purified L1
ectodomain showed that the FN-like repeats assume a
tight globular configuration (Drescher et al., 1996). Any
conformational lability within this structure may, there-
fore, provide a mechanism for translating distal ligation
events into signaling events. In a further study, Holm et al.
(1995) demonstrated that certain FN-like domain frag-
ments have a capacity for homoaggregation, suggesting
that one or more of the FN-like domains may have the po-
tential for self-association, perhaps leading to the cluster-
ing of L1 at the cell surface; such clustering may in turn be
subject to conformational constraints imposed by the glob-
ular configuration of the FN-like repeats.
In this study, we have identified moieties within the
third FN-like repeat of L1 (FN3) that can simultaneously
potentiate receptor clustering and integrin recruitment.
Both multimerization of, and integrin binding to, the FN3
domain are shown to be critically regulated by conforma-
tional constraints imposed by other domains and by pro-
teolysis. Several integrins are implicated in binding to the
FN3 domain including 
 
a
 
v
 
b
 
3
 
, 
 
a
 
5
 
b
 
1
 
, and 
 
a
 
9
 
b
 
1
 
. Based on our
findings, we propose that ligation events at the cell–cell in-
terface may induce a conformation change within the L1
ectodomain that culminates in receptor multimerization
and integrin recruitment via the FN3 domain. This para-
digm has important implications for L1 signaling and for
the modulation of integrin activity during cell–cell interac-
tions.
 
Materials and Methods
 
Reagents
 
Antiintegrin antibodies used in this study include the following: anti-
 
b
 
1
 
mAbs P4C10, LM534, B44, and Cl. 18; anti-
 
a
 
5
 
b
 
1 
 
mAbs P1D6 and NKI-
SAM-1, anti-
 
a
 
5 
 
mAb Cl.1, anti-
 
a
 
9
 
b
 
1 
 
mAb Y9A2; anti-
 
a
 
v
 
b
 
3 
 
mAb LM609;
anti-
 
b
 
3 
 
antibody AP3; anti-
 
b
 
5 
 
antibody 11D1; and an anti-
 
a
 
v
 
/anti-
 
b
 
3 
 
(anti-
 
VNR) polyclonal antibody (pAb). mAbs B44, P1D6, and Y9A2 were
purchased from Chemicon International. mAbs Cl. 18 and Cl.1 were pur-
chased from Transduction Laboratories. mAb NKI-SAM-1 was pur-
chased from Southern Biotechnology. mAb P4C10 was provided by Dr.
E.A. Wayner (University of Minnesota, Minneapolis, MN). LM609, the
anti–human L1 mAb 5G3 (Mujoo et al., 1986), the anti–L1-Ig6 mAb
LP1B9, the anti-VNR pAb, and the anti-5G3 Ag pAb were generated
 
within the Scripps Research Institute. Antibodies AP3 and 11D1 were
provided by Dr. David Cheresh (The Scripps Research Institute). An
anti–L1 ectodomain (anti–L1-ECD) pAb was generated against, and af-
finity-purified using the L1 ectodomain fusion protein. A pAb specific for
glutathione S-transferase (GST) was purchased from Upstate Biotechnol-
ogy Inc. L1 peptides were synthesized on an ABI 430A peptide synthe-
sizer within The Scripps Research Institute Core Facility as described
previously (Felding-Habermann et al., 1997). For the purpose of immobi-
lization, most peptides were made with NH
 
2
 
-terminal cysteine residues.
RGD and RGE control peptides were as follows: GRGDSPC and
GRGESPC. Human plasmin was purchased from Calbiochem.
 
Cell Lines and Culture
 
M21 human melanoma cells were derived from the UCLA-SO-M21 cell
line, which was provided by Dr. D.L. Morton (University of California,
Los Angeles, CA). Variant 
 
a
 
v-integrin–deficient cells (M21-L) were nega-
tively selected from M21 cells by FACS at The Scripps Research Institute.
All cells were maintained in RPMI-1640 supplemented with 10% FCS.
Transfected CHO cells bearing the human 
 
a
 
9
 
 integrin subunit were gener-
ated in the laboratory of Dr. Sheppard and cultured as described (Taooka
et al., 1999).
 
Construction and Expression of L1 Fusion Proteins
 
The recombinant L1 fusion proteins shown in Table I (schematic) were
generated by PCR amplification of appropriate coding sequences and re-
striction cloned into the appropriate fusion vector based upon the re-
quired tag and reading frame. Primer sequences and their corresponding
L1 amino acid start (sense oligos) or stop (antisense oligos) translation 
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sites, as well as the restriction enzymes used for insertion of the respective
PCR products into the respective fusion protein vectors, are shown in Ta-
ble I. Plasmids were purchased from Amersham Pharmacia Biotech or
GIBCO BRL for pGEX GST fusion vectors or pProEX 6
 
3
 
His fusion vec-
tors, respectively. Mutagenesis of the FN3 construct was performed essen-
tially as described previously (Nayeem et al., 1999). In brief, mutagenic
sense and antisense oligonucleotides (Table I) were annealed and ex-
tended with 
 
Pfu
 
 polymerase for a total of 18 cycles. Nonmutant starting
material was digested with DpnI and the final product was transformed
into supercompetent 
 
Escherichia coli
 
. Final constructs were confirmed by
dideoxy sequencing.
Purification of the recombinant fusion proteins was performed from log
phase BL21 strain 
 
E. coli
 
 induced with either 100 
 
m
 
M (GST) or 600 
 
m
 
M
isopropyl-
 
b
 
-
 
D
 
-thiogalactopyranoside (6
 
3
 
His). GST fusion protein purifi-
cation was performed as previously described (Nayeem et al., 1999). For
His fusion protein purification, cultures were resuspended in lysis buffer
(50 mM Tris-HCl, pH 8.5, 300 mM KCl, 20 mM imidazole, and 0.1% Tri-
ton X-100–containing protease inhibitors) and incubated with 100 
 
m
 
g/ml
lysozyme at 4
 
8
 
C. Lysates were clarified by centrifugation and fusion pro-
teins were immobilized on Ni-NTA agarose (Qiagen) before extensive
washing of the matrix with lysis buffer, followed by washing with 50 mM
Tris-HCl, pH 8.5, 500 mM KCl, 40 mM imidazole, and elution with 20 mM
Tris-HCl, pH 8.5, 300 mM KCl, 250 mM imidazole. Purified GST and His
fusion proteins were dialyzed extensively against PBS.
 
Adhesion Assays
 
Adhesion assays were performed essentially as described previously
(Felding-Habermann et al., 1997). In brief, purified L1 fusion proteins
(100–250 nM) were spotted (2-
 
m
 
l spots) or coated (100 
 
m
 
l) onto the bot-
tom of 96-well Titertek plates (ICN Biomedicals) and allowed to coat for
1–2 h at 37
 
8
 
C before blocking with 5% BSA. For adhesion studies involv-
ing immobilized peptides, wells were precoated overnight with murine
IgG2a antibody before incubation with the heterobifunctional cross-linker
SPDP (Pierce Chemical Co.), washing and incubation with peptides at
100–200 
 
m
 
g/ml for 2–3 h before blocking with 5% BSA. Control wells re-
ceived antibody and SPDP alone without peptide. Cells were harvested
and resuspended in adhesion buffer (HBSS, 10 mM Hepes, 0.5% BSA,
pH 7.4) containing divalent cations (0.4 mM MnCl
 
2
 
, 1 mM MgCl
 
2
 
, 1 mM
CaCl
 
2
 
) with or without antiintegrin function-blocking antibodies. For as-
says with 
 
a
 
v
 
(
 
2
 
)M21-L cells, adhesion was determined in the presence of
0.4 mM MnCl
 
2
 
 alone. Cells were added at 10
 
5 
 
cells/well in the presence or
absence of antibodies, and the plates were spun at 700 rpm to give a con-
tinuous monolayer. After 15–40 min at 37
 
8
 
C wells were washed with PBS,
and the remaining adherent cells were fixed with 1% paraformaldehyde
before counting the number of cells per high power field using a 40
 
3
 
 ob-
jective and an ocular grid at a minimum of four areas per well. Experi-
mental treatments were performed in triplicate.
 
Fractionation and Detection of L1-His Fusion Proteins
 
L1-FN3 (His) fusion proteins (5 
 
m
 
g) were fractionated at a flow rate of
0.180 ml/min using a 40-ml bed volume Sephacryl S-200 column (Amer-
sham Pharmacia Biotech). Fractions of 250 
 
m
 
l were collected, and 100 
 
m
 
l
of each fraction was applied per well of a Ni-NTA HisSorb plate (Qiagen)
for overnight immobilization at 4
 
8
 
C. Wells were subsequently washed with
0.5% BSA in PBS (BSA/PBS) before detection of bound His fusion pro-
tein as follows. Wells were incubated with anti–L1-ECD pAb for 1 h with
 
Table I. Oligonucleotide Primers Used in the Construction of Recombinant L1 Domains
 
Underlined bases represent sequences responsible for mutations in mutagenesis primers and restriction sites in PCR primers. 
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constant shaking before being washed at least five times with BSA/PBS
and subsequently incubated with HRP-conjugated goat anti–rabbit sec-
ondary antibody (Jackson ImmunoResearch Laboratories). Wells were
washed further and bound antibody was detected colorimetrically with
TMB (Bio-Rad Laboratories). Color development was arrested with
H
 
2
 
SO
 
4
 
, and the plates were read at 450 nm on a microplate reader (Ki-
netic Microplate Reader; Molecular Devices).
 
Integrin-binding Assays
 
Purified 
 
a
 
v
 
b
 
3 
 
and 
 
a
 
5
 
b
 
1 
 
integrin heterodimers were purchased from Chemi-
con International. Integrin 
 
a
 
v
 
b
 
3
 
 was biotinylated using NHS-LC-biotin
(Pierce Chemical Co.). L1 fusion proteins (10–40 
 
m
 
g/ml) were adsorbed
overnight at 4
 
8
 
C onto 96-well Titertek plates. Alternatively, 20 
 
m
 
g/ml of
rabbit Ig was adsorbed before incubation with SPDP and immobilization
of various peptides as described above for adhesion assays. After coating,
the wells were washed and blocked with 0.5% BSA in TBS buffer. Puri-
fied integrin heterodimers were added at 1 
 
m
 
g/ml in TBS supplemented
with 0.4 mM MnCl
 
2
 
 and 0.5% BSA. After washing, bound 
 
a
 
v
 
b
 
3
 
 was de-
tected with an HRP-conjugated antibiotin mAb (Sigma Chemical Co.).
Bound 
 
a
 
5
 
b
 
1
 
 was detected with anti-
 
a
 
5
 
b
 
1
 
 mAb NKI-SAM-1, followed by
HRP-conjugated goat anti–mouse Ig (Jackson ImmunoResearch Labora-
tories). Color was developed with TMB or OPD (Sigma Chemical Co.)
and plates were read at 450 nm. Control wells received no integrin or were
not coated with the L1 fusion protein. To assess the equivalent coating of
immobilized GST fusion proteins, parallel wells were blocked with BSA/
PBS, incubated with an anti-GST pAb, washed further, and incubated
with an HRP-conjugated goat anti–rabbit antibody before colorimetric
detection with either TMB or OPD at 450 nm.
 
Double Immunofluorescence
 
Aggregated nonadherent 
 
a
 
v
 
(
 
2
 
)M21-L melanoma cells from routine tissue
culture were harvested, washed, and resuspended in ice-cold FACS buffer
(BSA/PBS with 0.05% NaN
 
3
 
) for incubation with both anti-
 
a
 
9
 
b
 
1
 
 mAb
Y9A2 and the anti–L1-ECD pAb. Cell aggregates were washed and dou-
ble stained with fluorochrome-conjugated affinity-purified donkey F(ab
 
9
 
)-
specific for mouse IgG (Texas red) or rabbit IgG (FITC), which had been
preadsorbed to minimize cross-reactivity (Jackson ImmunoResearch Lab-
oratories). Stained cell aggregates were mounted and analyzed using an
MRC 1024 confocal microscope (Bio-Rad Laboratories) or a Nikon
Eclipse E800 fluorescent microscope. Some stained cell aggregates were
gently disrupted by pipetting in the presence of 1% paraformaldehyde,
and single cells were assessed for L1 and 
 
a
 
9
 
b
 
1
 
 colocalization. In further
studies, all of the experimental steps described above were performed at
37
 
8
 
C in the absence of sodium azide.
 
Immunoprecipitation
 
For analysis of the coprecipitation of L1 with integrin 
 
a9b1, av(2)M21-L
cells were cultured until the nonadherent fraction contained numerous ag-
gregates, at which time the adherent population was composed largely of
independent cells. The nonadherent population was harvested, washed,
and lysed in 50 mM Tris 7.6, 300 mM NaCl, 0.5% Triton X-100–containing
protease inhibitors. Adherent cells were washed and lysed on the plate,
and both adherent and nonadherent samples were clarified of Triton-
insoluble material. Equal quantities of adherent and nonadherent cell ly-
sate (3.5 mg) were precleared with protein G–Sepharose (Pierce Chemical
Co.) before overnight incubation with 5 mg anti-a9b1 mAb Y9A2. Anti-
body–antigen complexes were precipitated with protein G–Sepharose,
washed with lysis buffer, and boiled in reducing SDS-PAGE sample
buffer before being subjected to SDS-PAGE and immunoblotting with an
anti–L1-ECD pAb and a combination of anti–b1 integrin mAbs B44 and
Cl. 18 as described below.
For studies on the coimmunoprecipitation of integrin subunits with L1,
M21 or M21-L cells were aggregated by rotation, harvested, allowed to
settle, and lysed as described above for the nonadherent M21-L popula-
tion. After clarification of the Triton-insoluble fraction, equal quantities
of lysate (7.5 mg) were precleared with protein A–Sepharose (Sigma
Chemical Co.) before overnight incubation with 15 mg of either anti-
5G3Ag pAb or a control anti-GST pAb. Antibody–antigen complexes
were precipitated with protein A–Sepharose and washed extensively with
lysis buffer (M21-L cells) or RIPA buffer (M21 cells) before boiling in
nonreducing SDS-PAGE buffer and separation by SDS-PAGE and im-
munoblotting as described below. Precipitated L1 and associated integrins
were detected with the appropriate antibody as follows: L1, mAb 5G3;
b1 integrin, mAb LM534; integrin a5, mAb Cl. 1; integrin b3, mAb AP3;
integrin b5, mAb 11D1.
SDS-PAGE and Immunoblotting
Peptides, purified proteins, or immunoprecipitates were prepared as de-
scribed and separated in the presence or absence of 2-mercaptoethanol
(as required) by SDS-PAGE on precast Tris-glycine gels (Novex). Sepa-
rated proteins were electroblotted as required to a PVDF membrane (Im-
mobilon-P; Millipore), which was subsequently blocked with 5% milk in
PBS. Appropriate primary antibodies were incubated for 1–2 h in TBS
containing 0.1% Tween 20 (TBS-T) and 0.5% milk, and bound primary
antibody was detected with either an HRP-conjugated goat anti–rabbit Ig
(Southern Biotechnology) or donkey anti–mouse Ig (Jackson ImmunoRe-
search Laboratories) preadsorbed to minimize cross-reactivity with the
precipitating immunoglobulins. Antibody complexes were visualized with
the chemiluminescent substrate PS-3 (Lumigen Inc.). Alternatively, gels
were fixed and processed for staining.
Results
The Third FN-like Repeat of L1 Promotes
RGD-independent b1 Integrin Interaction with the
L1 Ectodomain
Previously, we have shown that the single RGD motif in
the sixth Ig-like domain (Ig6) of human L1 is recognized
by multiple integrin heterodimers, with the contribution of
each of these integrins being dictated by cell type and the
cation environment (Felding-Habermann et al., 1997). In a
physiological cation environment, the adhesion of M21
melanoma cells to the Ig6 domain was found to be solely
dependent on integrin avb3 (Montgomery et al., 1996).
While these studies established the importance of the
RGD motif in the context of individual domain fragments,
integrin recognition of the intact L1 ectodomain was not
addressed.
Significant dose-dependent adhesion of M21 cells was
observed on immobilized fusion proteins consisting of ei-
ther the Ig6 domain alone or the entire L1 ectodomain
(Fig. 1 a). However, inhibition studies using function-
blocking antibodies to either avb3 or b1 integrin demon-
strated a significant disparity in the contribution of these
integrins to adhesion on the two substrates (Fig. 1 b).
Thus, blocking ligation by avb3 resulted in a complete ab-
rogation of adhesion to Ig6, but was only partially effective
when the entire L1 ectodomain was used as a substrate
(Fig. 1 b). This disparity can be attributed to supplemental
b1 integrin recognition of the L1 ectodomain, as adhesion
to the L1 ectodomain could only be fully blocked with a
combination of antibodies to both avb3 and b1 integrins
(Fig. 1 b; right). 
These findings indicate that recognition of the RGD
motif in L1-Ig6 can only partially account for the full mea-
sure of integrin binding to the entire L1 ectodomain. One
possible explanation for this disparity is the presence of a
second non-RGD motif recognized by one or more b1
integrins. To identify the location of this motif, we gener-
ated multidomain L1 fragments containing the Ig6 domain
and adjacent FN-like repeats. While the addition of the
first and second proximal FN-like repeats of L1 (Ig6-FN1-2)
failed to result in supplemental b1 integrin binding (Fig. 1
c, left) inclusion of the third FN-like repeat (Ig6-FN1-3)
did result in adhesion by both avb3 and b1 integrin(s) (Fig.
1 c, right). These data indicate that recognition of sitesSilletti et al. L1 Multimerization and Integrin Ligation 1489
within Ig6 (RGD) and the third FN-like repeat (FN3; non-
RGD), can fully account for integrin binding to the L1
ectodomain. It should be noted that the Ig-like domains
proximal to Ig6 (i.e., Ig5 and Ig4) had no influence on inte-
grin recognition (data not shown).
The Heterodimers a5b1 and a9b1 Are Responsible for b1 
Recognition of the Third FN-like Repeat of L1
A panel of antiintegrin antibodies was tested to identify
the b1 integrin(s) responsible for recognition of the L1
ectodomain. These antibodies were first tested in adhesion
assays using M21 cells selected for a lack of av integrin ex-
pression (i.e., M21-L cells). Because of the absence of avb3
expression, M21-L cell adhesion to L1-Ig6 or L1-Ig6-FN1-2
was minimal (Fig. 2 a). Consistent with b1 integrin recogni-
tion of the third FN-like repeat, a marked increase in ad-
hesion was observed on either Ig6-FN1-3 or on the L1
ectodomain (Fig. 2 a). Adhesion of av(2)M21-L cells to
both of these substrates was examined in the presence of
function-blocking antibodies to a variety of b1 integrins in-
cluding a1b1, a2b1, a3b1, a4b1, a5b1, a6b1, and a9b1. From
these studies, it was confirmed that adhesion could only
be abrogated using a combination of mAbs specific for
both a5b1 and a9b1 (Fig. 2 b). Results obtained with the
av(2)M21-L cells could be reproduced with wild-type
M21 cells provided avb3 binding by these cells was also
blocked (Fig. 2 c). It should be noted that whereas wild-
type M21 cells were able to utilize a5b1 and a9b1 for adhe-
sion in a physiological cation environment (i.e., 1 mM
Ca21, 1 mM Mg21, 0.4 mM Mn21), av(2)M21-L cells only
showed significant adhesion via these integrins in an acti-
vating cation environment consisting of 0.4 mM Mn21
alone. This unexpected finding suggests that the selection
of M21 cells lacking av integrin expression has had an un-
foreseen effect on the activation state of these b1 integrins.
The Third FN-like Repeat (FN3) Alone Supports 
Integrin Ligation But Recognition of This Domain Is 
Regulated by Upstream FN1
To confirm that a second integrin recognition motif is
present in the FN3 repeat, we generated a further series of
L1 domain fragments consisting of single or multiple FN-
like repeats, including FN3 alone as well as FN2-3 and
FN1-3. L1 domain fragments consisting of FN1 alone and
FN1-2 were generated as controls.
M21 cells failed to adhere to either FN1 or FN1-2, but
Figure 1. RGD-independent b1 integrin binding to the L1
ectodomain involves the third FN-like repeat. (a) Adhesion of M21
cells to immobilized L1 ectodomain or domain Ig6 alone. (b) M21
adhesion to L1 ectodomain or Ig6 in the presence or absence of
function-blocking antibody to avb3 (LM609), b1 integrins (P4C10),
av integrins (anti-VNR), or both av and b1 integrins. (c) M21 ad-
hesion to Ig6 with adjacent FN-like repeats (Ig6-FN1-2 and Ig6-
FN1-3) in the presence or absence of function-blocking antibodies.
Data shown is the mean of triplicate measurements 6 SD.
Figure 2. The third FN-like repeat of L1 is recognized by inte-
grins a5b1 and a9b1. (a) Adhesion of av(2)M21-L cells to immo-
bilized L1 ectodomain, the Ig6 domain alone, or Ig6 in conjunc-
tion with adjacent FN-like repeats (Ig6-FN1-2 and Ig6-FN1-3). (b
and c) Adhesion of av(2)M21-L (b) or M21 cells (c) to L1
ectodomain or Ig6-FN1-3 in the presence or absence of function-
blocking antibody to avb3 (LM609), a5b1 (P1D6), or a9b1
(Y9A2), alone or in combination. Data shown are the mean of
triplicate measurements 6 SD.The Journal of Cell Biology, Volume 149, 2000 1490
did display significant dose-dependent adhesion to the
FN3 domain alone (Fig. 3 a). These findings confirm the
importance of FN3 in adhesion and demonstrate that this
domain can support adhesion independent of the RGD
motif in Ig6. However, it is important to note that adhe-
sion to FN3 was markedly reduced when this domain was
offered together with both FN1 and FN2 domains (Fig. 3
a, FN1-3). This effect can be attributed to the presence of
the first FN repeat (FN1) since adhesion to FN2-3 did not
differ markedly from adhesion to FN3 alone (Fig. 3 a).
Several explanations could account for the disparity in ad-
hesion observed between the FN3 and FN1-3 domain con-
structs, including unequal adsorption of the GST fusion
proteins. To exclude this possibility, we assessed the rela-
tive coating efficiency of the FN domain constructs by
measuring the amount of immobilized GST present in
coated wells. When offered at slightly different concentra-
tions, which resulted in equalization of GST immunoreac-
tivity (Fig. 3 b, inset), the significant disparity in adhesion
between FN3 and FN1-3 was still observed, even though
relatively high amounts of fusion protein were offered
(Fig. 3 b). It is important to note that cell spreading was
also markedly reduced on FN1-3, and that at lower coating
concentrations, the disparity in adhesion between FN3 and
FN1-3 was even more marked (Fig. 3 a). A further expla-
nation for this reduced adhesion associated with the pres-
ence of FN1 would be an interaction between this domain
and a cellular ligand that negatively regulates integrin liga-
tion. However, it should be noted that FN1 did not impact
integrin-mediated adhesion to Ig6. Thus, adhesion to a
construct consisting of Ig6 and FN1 was not significantly
different from that to Ig6 alone (Fig. 3 c).
To confirm that the adhesion observed with the FN3
domain alone is due to ligation of a5b1 and a9b1, further
inhibition studies were performed with both M21 and
av(2)M21-L cells. As expected, av(2)M21-L cell adhesion
to both FN3 and FN1-3 was reduced by function-blocking
antibodies to both a5b1 and a9b1 (Fig. 4 a). Wild-type M21
Figure 3. Adhesion to the
third FN-like repeat of L1
(FN3) is regulated by the first
FN-like repeat (FN1). (a) M21
adhesion to immobilized sin-
gle domain fragments (FN1
and FN3) and multiple do-
main fragments (FN1-2,
FN1-3,  and FN2-3). (b) M21
adhesion to the immobilized
FN domain fragments after
equalizing for protein adsorp-
tion as determined by ELISA
detection of GST (b, inset).
(c) Adhesion of M21 cells to
immobilized Ig6 or Ig6-FN1.
Data shown are the mean of
triplicate measurements 6 SD.
Figure 4. The FN3 domain alone is recognized by avb3 as well as
a5b1 and a9b1, but this interaction is markedly inhibited by the
FN1 domain. (a) Adhesion of av(2)M21-L cells to immobilized
FN3 alone or FN3 with the adjacent first and second FN-like do-
mains (FN1-3) in the presence or absence of function-blocking
antibodies to a5b1 (P1D6) or a9b1 (Y9A2). (b) Adhesion of M21
cells to immobilized FN 3 or FN1-3 in the presence or absence of
function blocking antibody to avb3 (LM609), a5b1 (P1D6), or
a9b1 (Y9A2), alone or in combination. (c) Mock-transfected
CHO cells were compared with CHO cells transfected with the
human integrin a9 subunit in the presence or absence of function-
blocking antibody to a9b1 (Y9A2). (d) Direct binding of purified
avb3 or a5b1 integrins to immobilized FN 3 or FN1-3 as deter-
mined by ELISA. The relative coating efficiency of the con-
structs was determined by anti-GST ELISA (inset). Data shown
are the mean of triplicate measurements 6 SD.Silletti et al. L1 Multimerization and Integrin Ligation 1491
cell adhesion to FN1-3 was similarly abrogated using a
combination of antibodies to a5b1 and a9b1 (Fig. 4 b, right).
Remarkably, and in contrast to adhesion on FN1-3, M21
cell adhesion to FN3 could only be completely abrogated
with the further addition of an antibody to avb3 (Fig. 4 b,
left). These findings suggest that part of the antiadhesive
activity of FN1 can be attributed to its capacity to signifi-
cantly limit recognition of FN3 by avb3. However, since
the adhesion of av(2)M21-L cells was also reduced in the
presence of FN1 (Fig. 4 a), it is likely that this domain also
limits recognition by a5b1 and a9b1. To further establish
that a9b1 can directly support adhesion on FN3, it was de-
termined that CHO cells transfected with the a9 subunit
(Taooka et al., 1999) are significantly more adherent on
FN3 than mock transfectants, and that the increased adhe-
sion observed can be inhibited with a function-blocking
antibody to a9b1 (Fig. 4 c).
To confirm direct integrin binding to FN3 and to dem-
onstrate regulation of this interaction by FN1, we per-
formed binding assays with purified a5b1 and avb3 het-
erodimers. The binding of these integrins to FN3 or FN1-3
substrates was compared in an ELISA-based assay (Fig. 4
d). Significant direct binding between both avb3 and a5b1
and FN3 was observed, and both of these interactions
were significantly reduced when FN1-3 was used as a sub-
strate (Fig. 4 d). This difference was observed despite a
slight disparity in coating efficiency, resulting in the avail-
ability of more FN1-3 substrate (Fig. 4 d, inset).
The findings presented clearly demonstrate that the
third FN-like repeat of L1 can be recognized by multiple
integrins including avb3, a5b1, and a9b1. However, such in-
teractions are markedly reduced in the presence of FN1.
This inhibition is most evident in the case of avb3 which,
when present, appears to have a dominant role in adhesion
to FN3, but recognizes FN1-3 poorly.
Sequences within the Putative B-C and C-C9 Loop 
Regions of FN3 Support Integrin Ligation
Integrin binding motifs in the FN- or Ig-like domains
of matrix components or cell adhesion molecules are
commonly situated on exposed loops or turns between
b-strands. To identify integrin recognition sequences in
FN3, we generated a series of peptides corresponding to
putative loop regions (Bateman et al., 1996). Two active
peptide sequences were identified within the putative B-C
and C-C9 loop regions of FN3.
A peptide based on the putative B-C loop sequence
RPVDLAQVKGHLR827 was found to support significant
M21 cell attachment (Fig. 5 a). Overlapping truncation
peptides from this sequence established the minimal active
sequence to be QVKGHLR827. Confirming an integrin-
dependent interaction, M21 adhesion to this peptide was
blocked using a combination of antibodies to both avb3
and a5b1 (Fig. 5 b). The adhesion of av(2)M21-L cells to
the QVKGHLR827 sequence was blocked by an antibody
to a5b1 alone but was unaffected by an mAb to a9b1 (Fig. 5
c). Based on amino acid substitution, both lysine823 and the
COOH-terminal arginine827 residues are essential for ad-
hesion to QVKGHLR827 (Fig. 5 d). Substitution of the
NH2-terminal glutamine821 residue partially reduced adhe-
sion, whereas mutation of histidine825 had no effect. Im-
portantly, the corresponding sequence in the mouse L1
homologue (i.e., QVKGHLK) was also able to support ad-
hesion (Fig. 5 d). To confirm direct integrin binding to im-
mobilized QVKGHLR827 peptide, binding assays were
performed with purified a5b1 and avb3 heterodimers (Fig.
5, e and f). Significant binding by both avb3 and a5b1 was
observed and, consistent with results obtained in the adhe-
sion assays, mutation of the lysine823 residue resulted in
the complete loss of binding by both integrins (Fig. 5, e
Figure 5. A sequence in the putative B-C loop of the FN3 do-
main supports adhesion via both avb3 and a5b1. (a) M21 adhesion
to an immobilized peptide corresponding to the putative B-C
loop of FN3 (RPVDLAQVKGHLR827) or overlapping trunca-
tion peptides of this sequence. (b) Adhesion of M21 cells to im-
mobilized peptide QVKGHLR827 in the presence or absence of
antibody to avb3 (LM609) or a5b1 (P1D6), alone or in combina-
tion. (c) Adhesion of av(2)M21-L cells to immobilized peptide
QVKGHLR827 in the presence or absence of antibodies to a9b1
(Y9A2) or a5b1 (P1D6). (d) M21 adhesion to peptides resulting
from alanine substitutions within the sequence QVKGHLR827. (e
and f) Direct binding of purified avb3 (e) or a5b1 (f) integrins to
immobilized QVKGHLR827 or QVAGHLR827 (mutant) peptide
as determined by ELISA. Soluble RGD or RGE peptide (50 mg/ml)
was added concurrently with the purified integrins. Mutated resi-
dues are underlined, and the data shown are the mean of tripli-
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and f, mutant). Significantly, specific inhibition of integrin
binding by the soluble RGD peptide (GRGDSPC) was
not detected (Fig. 5, e and f).
A further peptide that was derived from a sequence in
the putative C-C9 loop region of FN3 (GSQRKHSKR-
HIHKDHV852) also supported significant cell adhesion
(Fig. 6 a). Independent alanine substitution of either of the
two dibasic RK841 and KR845 sequences within the peptide
resulted in a minor loss of cell adhesion, whereas simulta-
neous mutation of both dibasic sequences abrogated cell
adhesion almost completely (Fig. 6 a). Alanine replace-
ment of a downstream KD850 sequence within the peptide
had a negligible effect on cell adhesion, demonstrating the
specificity of cell adhesion for the two dibasic sequences.
Consistent with these findings, significant cell adhesion
was also observed on a 9-mer peptide corresponding to the
first half of the entire C-C9 loop peptide (GSQRKH-
SKR845), but not a peptide corresponding to the second
half of the C-C9 loop (HIHKDHV852; Fig. 6 a). M21 adhe-
sion to the wild-type C-C9 loop peptide GSQRKHSKR-
HIHKDHV852 was partially blocked using a combination
of antibodies to a5b1 and avb3 (Fig. 6 b), whereas the adhe-
sion of av(2)M21-L cells was also partially blocked by in-
hibition of a5b1, but was not significantly affected by an
antibody to a9b1 (Fig. 6 c). It is important to note that
a component of M21 cell adhesion to the wild-type
GSQRKHSKRHIHKDHV852 peptide was found to be in-
tegrin-independent, with some degree of adhesion evident
even in the presence of EDTA (data not shown).
To confirm direct integrin binding to the immobilized
GSQRKHSKRHIHKDHV852 peptide, binding assays were
performed with purified a5b1 and avb3 heterodimers (Fig.
6, d and e). Significant binding to the wild-type peptide by
both avb3 and a5b1 was observed, and independent alanine
substitution of either of the two dibasic RK841 and KR845
sequences resulted in some loss of binding by both inte-
grins. Concurrent mutation of both dibasic sequences
completely abolished binding by both avb3 and a5b1 (Fig.
6, d and e), which is consistent with results obtained in the
adhesion assays. As expected, both integrins bound to the
first half of the wild-type peptide exclusively, demonstrat-
ing little or no interaction with the second half of the pep-
tide. As with integrin binding to the B-C loop peptide,
binding of avb3 and a5b1 integrins to the C-C9 loop peptide
was not specifically inhibited by the soluble RGD peptide
(data not shown).
Site-directed mutagenesis of key residues within the pu-
tative B-C and C-C9 loop regions of FN3 was performed
to confirm that they are required for integrin recognition
in the context of the whole domain. Specifically, the se-
quence QVKGHLR827 in the putative B-C loop was mu-
tated to QVAGHLR827, whereas the GSQRKHSKRHI-
HKDHV852 sequence constituting the C-C9 loop was
mutated to GSQNNHSNNHIHKDHV852. Conservative
asparagine substitutions were generated within the C-C9
loop to minimize unforeseen effects on domain structure,
and both of the dibasic RK841 and KR845 sequences were
substituted since both were found to contribute to integrin
binding (Fig. 6). While the wild-type FN3 domain sup-
ported both M21 and av(2)M21-L adhesion at concentra-
tions as low as 50–75 nM, this adhesion was markedly re-
duced after substitution of the dibasic sets of lysine and
arginine residues in the putative C-C9 loop (Fig. 7, a and
b). Mutation of the single lysine823 residue in the putative
B-C loop had a relatively small but significant effect on ad-
hesion, which was principally evident at lower coating con-
centrations (Fig. 7, a and b). To confirm the primary im-
portance of the C-C9 loop sequence, direct binding assays
were performed with purified a5b1 and avb3 integrins. In
agreement with the integrin binding results obtained using
peptides, ligation of both integrins to the FN3 domain was
dose-dependent and saturable, and exhibited significant
Figure 6. A sequence in the putative C-C9 loop of the FN3 do-
main supports adhesion and is recognized by both avb3 and a5b1.
(a) M21 adhesion to an immobilized peptide derived from a se-
quence in the putative C-C9 loop of FN3 (GSQRKHSKRHIH-
KDHV852) or peptides resulting from alanine substitution or
truncation. (b) Adhesion of M21 cells to immobilized wild-type
peptide GSQRKHSKRHIHKDHV852 in the presence or absence
of antibodies to avb3 (LM609), a5b1  (P1D6), or b1  integrins
(P4C10), alone or in combination. (c) Adhesion of av(2)M21-L
cells to immobilized wild-type peptide GSQRKHSKRHIH-
KDHV852 in the presence or absence of antibodies to a9b1
(Y9A2) or a5b1 (P1D6). (d and e) ELISA determination of the
direct binding of purified avb3 (d) or a5b1 integrins (e) to immobi-
lized wild-type GSQRKHSKRHIHKDHV852 or mutant peptides
derived by alanine substitution or truncation. Mutated residues
are underlined, and the data shown are the mean of triplicate
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susceptibility to mutations within the C-C9 loop (Fig. 7, c
and d).
Based on our findings, we propose that the FN3 domain
of L1 contains two novel integrin binding motifs that ac-
count for RGD-independent recognition by a5b1 and avb3.
Substitution studies demonstrate that the dibasic RK841
and KR845 sequences present in the putative C-C9 loop of
FN3 are of primary importance for integrin recognition. A
second motif in the putative B-C loop of the FN3 domain
(QVKGHLR/K827) also contributes to a5b1 and avb3 bind-
ing, albeit to a lesser degree. It is important to note that
both QVKGHLR827 and GSQRKHSKRHIHKDHV852 pep-
tides were ineffective as soluble antagonists in as much as
they failed to inhibit adhesion to themselves. Indeed, a
paradoxical increase in adhesion was often observed when
these peptides were offered during the adhesion assay
(data not shown). One explanation for this effect would be
that the soluble peptides can self-associate with the immo-
bilized peptide, thereby resulting in multimerized peptide
which is then recognized by integrin avb3 and/or a5b1.
While we have obtained clear evidence that a9b1 can sup-
port adhesion to FN3, we failed to identify the binding mo-
tif. It may prove that recognition by this integrin is subject
to conformational constraints that are violated by the use
of linear peptides.
Integrins Recognize Multimerized FN3 and 
Homoaggregation of This Domain Is Regulated by the 
Dibasic Sequences in the Putative C-C9 Loop and by the 
Presence of FN1
Purified FN3 and FN2-3 fusion proteins (GST or His)
were both observed to precipitate at high protein concen-
trations, suggesting a propensity for homoaggregation. In
contrast, such precipitation was not observed with either
Ig6-FN1-3 or FN1-3 fusion proteins. These observations,
coupled with the prior observation that the presence of
FN1 is inhibitory to cell adhesion on FN3, raised the possi-
bility that integrins preferentially recognize the FN3 do-
main as a homomultimer and that inhibition of integrin
recognition by FN1 is related to the ability of this domain
to inhibit such multimerization. It was also observed that
precipitation of the FN3 domain was markedly reduced af-
ter substitution of the dibasic RK841 and KR845 sequences
present in the putative C-C9 loop sequence of FN3. This
raised the further possibility that the peptide sequence
GSQRKHSKRHIHKDHV852, which is of primary impor-
tance for integrin recognition, is also important for FN3
homomultimerization. Indeed, a propensity for self-associ-
ation by the GSQRKHSKRHIHKDHV852 peptide could
explain the paradoxical finding that this peptide can func-
tion as a soluble agonist in adhesion assays. Confirmation
of this hypothesis would require that several stipulations
be fulfilled: (1) FN3 is multimerized at the time of integrin
recognition; (2) the presence of FN1 limits FN3-medi-
ated multimerization; and (3) the GSQRKHSKRHIHK-
DHV852 peptide self-associates and mutation of the C-C9
loop sequence, which results in a loss of integrin recogni-
tion, also prevents multimerization.
As a first step, we looked for evidence of FN3 multimer-
ization by both column chromatography and SDS-PAGE.
To avoid potential complexities associated with the pres-
ence of GST as a fusion partner, these studies were per-
formed with an FN3-His construct. After gel filtration on a
Sephracryl S-200 column, the FN3 domain was observed
to elute as a series of high molecular mass complexes (Fig.
8 a, top). Based on size relative to molecular mass stan-
dards, the smallest complexes were trimers (33) and hexa-
mers (63), with relatively little monomer (13) evident.
The relative proportion of monomer present in different
preparations varied with some preparations having little
or no evidence of any monomer whatsoever. It should be
noted that any precipitate present in the FN3 preparations
was removed by centrifugation before fractionation by
column chromatography. In support of these findings with
the FN3-His protein, separation of the FN3-GST prepara-
tion also revealed the presence of trimeric and higher or-
der complexes (data not shown).
Upon SDS-PAGE resolution under nondenaturing con-
ditions (i.e., without boiling), most of the FN3–His com-
plexes were resolved into the monomer (16 kD, 13; Fig. 8
b, lane 1). However, even in the presence of SDS, a signifi-
cant amount of trimeric FN3 (48 kD, 33) was detected.
Depending upon the amount of material loaded, small
amounts of hexameric FN3 (96 kD, 63) and sometimes
even higher order species could also be detected (Fig. 8 b,
lane 1). Taken together, these data demonstrate that, un-
der native conditions, the FN3 domain self-associates to
Figure 7. Substitution of the dibasic sequences in the putative
C-C9 loop of the FN3 domain suppresses adhesion and direct in-
tegrin binding. (a and b) Adhesion of M21 (a) or av(2)M21-L
cells (b) to wild-type FN3 domain or mutant FN3 domains con-
taining conservative asparagine substitution of the two dibasic se-
quences within the C-C9 loop (RK841 and KR845), or a single
lysine823 to alanine823 substitution within the B-C loop. (c and d)
ELISA determination of the direct binding of purified avb3 (c) or
a5b1 integrins (d) to immobilized wild-type FN3 domain or mu-
tant FN3 containing asparagine substitutions within the C-C9
loop. Data shown are the mean of triplicate measurements 6 SD.The Journal of Cell Biology, Volume 149, 2000 1494
form large multimeric complexes and that the most stable
multimeric configuration appears to be a trimer (SDS-
PAGE), which can further self-associate to form higher
order complexes (gel filtration).
Importantly, substitution of the dibasic RK841 and KR845
sequences present in the putative C-C9 loop sequence of
FN3, which effectively abrogated integrin binding, was
also found to limit FN3 multimerization. This is demon-
strated by the large amount of monomeric FN3 evident on
fractionation (Fig. 8 a, bottom) and by an almost complete
absence of trimeric FN3 (33) evident on SDS-PAGE (Fig.
8 b, lane 2). The small amount of complexed FN3 remain-
ing despite mutation of the dibasic sequences likely re-
flects the conservative substitution of the arginine and
lysine residues with asparagines. In contrast, alanine muta-
tion of the lysine823 residue in the putative B-C loop, which
only marginally effected adhesion, did not obviously effect
the multimerization of FN3 (Fig. 8 b, lane 3). This lack of
effect on domain multimerization was also observed upon
fractionation of the lysine823 mutant by gel filtration (data
not shown). Together, these data suggest that integrin
binding to FN3 primarily involves recognition of mul-
timers.
Confirming the hypothesis proposed above, a compari-
son of complex formation by FN1-3 versus FN3 dem-
onstrates that the presence of FN1 does indeed limit mul-
timerization mediated by the FN3 domain. Thus, the
proportion of trimeric FN1-3 (140 kD, 33) evident on
SDS-PAGE was found to be markedly lower than that ob-
served with both FN3 (Fig. 8 b, lane 1) and FN2-3 (Fig. 8
c). That the FN2-3 construct forms complexes as effi-
ciently as FN3 is consistent with the ability of this two-
domain construct to support adhesion at levels equivalent
to FN3 alone (Fig. 3 a). The observation that FN1-3 is still
capable of limited multimerization may explain why FN1-3
can still be recognized by integrins at high coating concen-
trations.
A final requirement of the hypothesis proposed above is
that the GSQRKHSKRHIHKDHV852 peptide derived
from the C-C9 loop of FN3 can self-associate and, as a re-
sult, support integrin recognition as a peptide complex.
This would support the concept that the C-C9 loop of FN3
promotes both multimerization and integrin binding. On
SDS-PAGE the 16-mer GSQRKHSKRHIHKDHV852
peptide, which has a predicted molecular mass of 2 kD,
was found to migrate as a primary species of z6 kD, indic-
ative of an SDS-stable tripeptide complex (Fig. 8 d, lane
2). A 15-mer peptide of 1.95 kD derived from the Ig6 do-
main of L1 (PSITWRGDGRDLQEL544) is shown for
comparison (Fig. 8 d, lane 1). Interestingly, separate ala-
nine substitution of either of the two dibasic RK841 or
KR845 sequences in the GSQRKHSKRHIHKDHV852 pep-
tide resulted in a reduction in molecular mass, which is
consistent with the formation of di- rather than tripeptide
complexes (Fig. 8 d, lanes 3 and 4). Finally, simultaneous
alanine replacement of both sets of dibasic residues re-
sulted in a peptide that resolved as a monomeric species
(Fig. 8 d, lane 5). Importantly, these same alanine substitu-
tions also abrogated cell adhesion and integrin binding
(Fig. 6). Taken together, these data indicate that optimal
integrin binding to the GSQRKHSKRHIHKDHV852 pep-
tide under native conditions involves recognition of tri-
peptide or higher order peptide complexes and confirms a
role for the dibasic RK841 and KR845 sequences in domain
and peptide multimerization.
Plasmin Regulates FN3 Multimerization and
Integrin Binding
Human L1, as well as related molecules in the mouse, rat
(NILE), and chick (Ng-CAM and Nr-CAM) have been
Figure 8. Homomultimerization of the FN3 domain is mediated
by dibasic sequences in the putative C-C9 loop and regulated by
the presence of FN1. (a) Sephacryl S-200 gel filtration elution
profiles of wild-type FN3 domain (top) or mutant FN3 containing
conservative asparagine substitution of the two dibasic sequences
(RK841 and KR845) within the C-C9 loop (bottom). Elution points
of monomer (13), trimer (33), and hexamer (63) in relation to
molecular mass standards are denoted. (b) SDS-PAGE analysis
of wild-type FN3 (lane 1), FN3 in which the two dibasic pairs
within the C-C9 loop are replaced with asparagines (lane 2), or
FN3 in which lysine823 within the B-C loop is replaced with ala-
nine (lane 3). Separated proteins were detected by immunoblot-
ting with the anti–L1 ECD pAb. (c) SDS-PAGE and immuno-
blot comparison of FN3 in conjunction with adjacent FN-like
domains (FN2-3 or FN1-3). The relative migration of monomeric
(13), trimeric (33), and hexameric species (63) are indicated.
(d) SDS-PAGE comparison of wild-type GSQRKHSKRH-
IHKDHV852 peptide (lane 2), with single dibasic alanine mutant
peptides (GSQAAHSKRHIHKDHV852, lane 3; GSQRKHS-
AAHIHKDHV852, lane 4) and the double dibasic alanine mutant
peptide (GSQAAHSAAHIHKDHV852, lane 5). A peptide de-
rived from the Ig6 domain of L1 (PSITWRGDGRDLQEL544) is
shown for comparison (lane 1). The relative migration of the pep-
tides in relation to molecular mass standards is shown at the left.Silletti et al. L1 Multimerization and Integrin Ligation 1495
shown to be sensitive to posttranslational cleavage within
the FN3 domain (Faissner et al., 1985; Sadoul et al., 1988;
Nybroe et al., 1990; Burgoon et al., 1995). Importantly, this
cleavage has been shown to involve the same dibasic
sequences that we have identified as important for inte-
grin binding and multimerization. Thus, trypsin has been
shown to cleave after the second dibasic sequence
(GSQRKHSKR¯HIHKDHV852; Faissner et al., 1985; Sa-
doul et al., 1988), whereas we have recently demonstrated
that plasmin cleaves both dibasic sequences (GSQ-
RK¯HSK¯RHIHKDHV852; Nayeem et al., 1999). Based
on this information, we questioned whether posttransla-
tional cleavage of the FN3 domain represents a mecha-
nism for regulating both multimerization and integrin
binding.
Treatment of FN3–His complexes with plasmin resulted
in a dose-dependent dissolution of the trimeric FN3 com-
plexes evident on SDS-PAGE (Fig. 9 a). A loss of trimeric
FN3 complexes was evident at plasmin concentrations as
low as 0.01 U/ml. Consistent with this finding, treatment of
immobilized FN3 substrate with plasmin at a concentra-
tion of 0.01 U/ml also resulted in a .60% inhibition of ad-
hesion by both M21 and av(2)M21-L cells (Fig. 9 b, right).
At the same concentration, plasmin had no effect on the
RGD-dependent adhesion of M21 cells to the Ig6 domain
of L1 (Fig. 9 b, left). Interestingly, plasmin treatment of
the L1 ectodomain also resulted in a marked inhibition of
adhesion by av(2)M21-L cells, but only marginally de-
creased adhesion by M21 cells (Fig. 9 b, middle). This
result is consistent with the finding that av(2)M21-L ad-
hesion to the L1 ectodomain is highly dependent on inter-
actions with the FN3 domain, while M21 cells can still
adhere via interaction with the RGD motif in the Ig6 do-
main. Together, these data support the concept that serine
protease–mediated cleavage within the FN3 domain is a
potentially important mechanism for regulating its func-
tional activity.
A Paradigm for L1–Integrin Interactions
Based on our findings, it is evident that FN1 limits homo-
multimerization via the FN3 domain. One possible expla-
nation for this would be steric hindrance in which the FN1
and FN3 domains are folded back upon one another in a
closed globular conformation. Homomultimerization via
the FN3 domain and concomitant integrin recruitment
may only occur after a change in conformation that pro-
motes a more extended open configuration. Homophilic
L1–L1 ligation via the Ig-like domains and/or integrin in-
teraction with the RGD motif in Ig6 may be mechanisms
for inducing such a change in conformation. A schematic
representation of such a model is shown in Fig. 10 a.
Certain predictions can be made based on the model pro-
posed. First, it should be possible to show that, as a result of
folding between FN1 and FN3, accessibility to certain do-
main regions will be limited. In this regard, an mAb specific
for an epitope in the Ig6 domain of L1 (mAb LP1B9) was
able to recognize Ig6-FN1 and Ig6-FN1-2, but was very lim-
ited in its ability to recognize Ig6-FN1-3 (Fig. 10 b). This re-
sult is hard to reconcile if Ig6-FN1-3 simply forms a linear
structure, but can be explained readily if there is a folding
event that juxtaposes FN3 with FN1 and Ig6.
A further prediction of the model presented is that inhi-
bition of upstream L1 ligation (e.g., homophilic L1–L1 li-
gation) will also inhibit integrin-dependent adhesion via
FN3 because the FN-like repeats will remain in a closed
conformation. In this regard, we observed that integrin-
dependent adhesion of av(2)M21-L cells to the L1 ec-
todomain could be significantly reduced by an antibody
(5G3) that blocks homophilic L1–L1 ligation by binding to
an NH2-terminal Ig-like domain (Montgomery et al., 1996;
Nayeem et al., 1999; Fig. 10 c, left). It is unlikely that this
antibody is inhibiting av(2)M21-L adhesion by directly
blocking integrin recognition of the FN3 domain since it
recognizes a distal epitope and fails to prevent integrin
binding to the Ig6 domain, which is located closer to the
antibody binding site. However, since av(2)M21-L cells
express high levels of L1, a homophilic interaction with the
immobilized L1 could induce the conformation change re-
quired for binding of these cells to FN3. The 5G3 antibody
was markedly less effective at preventing M21 cell adhe-
sion to the L1 ectodomain (Fig. 10 c, right), presumably
because these cells are still able to recognize the RGD mo-
tif in the Ig6 domain via avb3. It is interesting to note that
the 5G3 antibody also had some minimal inhibitory activ-
ity when the FN3 domain alone was offered as a substrate
(Fig. 10 c). This inhibition may indicate a limited but direct
interaction between cellular L1 and the immobilized FN3
Figure 9. Plasmin regulates FN3 multimerization and integrin
binding. (a) SDS-PAGE and immunoblotting analysis of com-
plexed wild-type FN3 treated with plasmin. FN3 in solution was
treated for 90 min with plasmin before SDS-PAGE and immuno-
blotting with the anti–L1-ECD pAb. The FN3 trimer band (48 kD)
was analyzed by scanning densitometry and graphed in arbitrary
density units. (b) Adhesion of M21 or av(2)M21-L cells to Ig6,
FN3, or L1 ectodomain treated with plasmin. Immobilized pro-
teins were treated with or without 0.01 U/ml plasmin for 90 min,
washed, and blocked before the addition of cells. Data shown are
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domain. In this regard, it has been shown that FN con-
structs containing the FN3 domain can interact with other
Ig-like domains present in the L1 ectodomain (Holm et al.,
1995).
Based on the premise that distal L1 ligation events are
required to promote FN3 multimerization and integrin re-
cruitment, it is also to be expected that L1 and integrins
will only colocalize at the cell–cell interface, where such
distal ligation events are expected to occur. Double im-
munofluorescence was performed to test this prediction.
The a9b1 integrin was selected for analysis since previous
studies with the av(2)M21-L cells demonstrated that this
integrin is primarily involved in adhesion to the FN3 do-
main rather than the RGD motif in Ig6. Aggregates of
av(2)M21-L cells were analyzed after simultaneous stain-
ing for a9b1 and L1. Both L1 and a9b1 were observed to be
recruited to sites of cell–cell contact (Fig. 11, a and b) and
significant colocalization is evident at these sites (Fig. 11, c
and d). However, it is also important to note that these
ligands do not appear to colocalize unless recruited to the
cell–cell interface as demonstrated by confocal micro-
scopic analysis (Fig. 11 d). Since the juxtaposition of two
cell membranes could give the illusion of colocalization, it
was further determined whether such colocalization is still
evident on single cells obtained after the gentle disruption
of stained cell aggregates. The disruption of cell aggre-
gates was performed with simultaneous fixation. Using
this approach, we observed significant modulation of both
L1 and a9b1 on some of the single cells obtained (Fig. 11, e
and f). Based on the absence of such obvious modulation
in the absence of prior aggregation, it is likely that areas of
modulation are a result of prior cell–cell contact. Impor-
tantly, even under these conditions, we still observed sig-
nificant colocalization of L1 and a9b1 (Fig. 11 g). Signifi-
cant colocalization was not observed on those single cells
that failed to display evidence of modulation (Fig. 11 g, as-
terisk). Adopting the same experimental approach, but
with all steps performed at 378C in the absence of sodium
azide, we observed further marked modulation of L1 and
a9b1 expression (Fig. 11, h and i), and again significant
colocalization was observed (Fig. 11 j). Colocalization be-
tween a9b1 and L1 on individual cells that were separated
from cell aggregates supports the concept of a cis-interac-
tion between these two ligands.
As a further test of a direct association between a9b1
and L1, coimmunoprecipitation studies were performed
using the anti-a9b1 mAb Y9A2. Cell lysates were made
from av(2)M21-L cells maintained as aggregates or as
subconfluent monolayers. These lysates were treated with
mAb Y9A2 and Western blot analysis was performed to
detect the presence of coprecipitated L1. Consistent with
an interaction at sites of cell–cell contact, L1 was readily
detected in Y9A2 immunoprecipitates derived from ly-
sates of aggregated av(2)M21-L cells (Fig. 11 k, Agg.). In
contrast, only minimal reactivity was evident in the lysate
derived from monolayer cultures (Fig. 11 k, Mono.). As
further confirmation of L1–integrin association, reverse
immunoprecipitation was performed using an anti-L1
polyclonal antibody (anti-5G3 Ag-pAb). In these studies,
Western blot analysis was performed to detect the pres-
ence of coprecipitated b1, a5, b3, and b5 integrin subunits.
Providing further evidence for a possible association be-
tween L1 and a9b1, Western blot analysis confirmed the
presence of the b1 integrin subunit in immunoprecipitates
derived from aggregated av(2)M21-L cells (Fig. 11 l). Be-
cause of a lack of antibodies suitable for the detection of
the a9 subunit by Western blotting, we cannot definitively
claim that the presence of the b1 integrin subunit is due to
the coprecipitation of a9b1. However, given that a9b1 both
colocalizes with and coprecipitates L1, it is likely that at
least a component of the b1
 present is due to its association
with a9. Consistent with reports that have indicated an as-
sociation between L1 and a5b1 and avb3, both b3 and a5 in-
tegrin subunits were also identified in immunoprecipitates
of aggregated M21 or M21-L cells (Fig. 11 l). In contrast,
despite the presence of significant amounts of avb5 in M21
Figure 10. L1 conformation and L1–L1 homophilic interaction
may regulate integrin recruitment via the FN3 domain. (a) A po-
tential model for the interaction between integrins and the FN3
domain of L1. The Ig- and FN-like domains of L1 are assumed to
form a closed globular conformation according to the findings of
Su et al. (1998) and Drescher et al. (1996). Distal ligation events
involving the Ig-like domains of L1 (L1–L1 or L1–integrin) are
postulated to cause a conformational change, resulting in a per-
missive open conformation that can support L1 clustering via
FN3 and subsequent integrin recruitment. Potential implications
of this multimerization and integrin recruitment include L1-inte-
grin–dependent signal transduction. (b) Anti-Ig6–specific mAb
(LP1B9) recognition of its epitope in the Ig6 domain alone, or
Ig6 with adjacent FN-like domains (Ig6-FN1-2 and Ig6-FN1-3) as
determined by ELISA. Immobilized proteins were incubated
with the anti–L1-Ig6 mAb LP1B9, washed, and were detected
colorimetrically with HRP-conjugated secondary antibody and
OPD. (c) Adhesion of M21 or av(2)M21-L cells to the L1
ectodomain (L1-ECD) or FN3 after pretreatment of cells with
the function-blocking anti-L1 mAb 5G3. Data shown are the
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cell lysates, no significant coprecipitation of the b5 subunit
was detected (Fig. 11 l). Importantly, none of the integrin
subunits were detected after immunoprecipitation using a
control antibody to GST (Fig. 11 l).
Based on the observation that L1–integrin colocaliza-
tion is primarily restricted to sites of cell–cell contact, it is
to be expected that only a small fraction of the available
integrin pool will be directly associated with L1. In our sys-
tem, despite attempts to maximize aggregation, we still ob-
served that many cells remained single and, even in aggre-
gates, we often observed variable recruitment into cell–cell
contact sites. It also needs to be recognized that some inte-
grins are sequestered in large intracellular pools. In the
case of the b1 integrin subunit, the amount specifically co-
Figure 11. Colocalization
and coimmunoprecipitation
of L1 and integrins after cell–
cell interaction. (a–c) Stain-
ing of M21-L cell cluster with
anti–L1-ECD pAb and the
anti-a9b1  mAb Y9A2. L1
staining is shown in green (a,
FITC),  a9b1  staining in red
(b, Texas red), and overlap-
ping fluorescence or colocal-
ization is evidenced as yellow
(c, Merge). Arrows denote
areas of colocalization at
points of cell–cell contact.
Images were obtained using
a 403 objective and a Nikon
Eclipse E800 fluorescent mi-
croscope. (d) Merged image
of L1 (green) and a9b1 (red)
staining of M21-L cell clus-
ters obtained using an MRC
1024 confocal microscope.
Note that colocalization is
primarily limited to cell–cell
interfaces (arrows). (e–g)
Disruption of stained M21-L
cell clusters with simulta-
neous fixation results in
some single cells with areas
of modulated L1 and a9b1 ex-
pression (e and f). Note that
there is still evidence of sig-
nificant colocalization be-
tween L1 and a9b1(g). No
significant localization was
observed in another cell that
failed to show evidence of L1
or a9b1 modulation (g, aster-
isk). (h–j) M21-L cell clusters
were stained at 378C and in
the absence of azide. After
disruption of cell aggregates,
some single cells showed evi-
dence of significant L1 and
a9b1 modulation (h and i).
Significant areas of colocal-
ization were observed (j). (k)
Coimmunoprecipitation of
L1 with an anti-a9b1 mAb.
Lysates were obtained from
aggregated av(2)M21-L cells
(Agg.) or their adherent sub-
confluent counterparts (Mono.). Precipitated proteins were immunoblotted to detect coprecipitated L1 or the immunoprecipitated b1
subunit of a9b1. (l) Reverse immunoprecipitation was performed using an anti-L1 pAb and lysates of aggregated M21-L or M21 cells. A
polyclonal antibody to GST was used as a control. Immunoprecipitated material was immunoblotted using antiintegrin antibodies as de-
scribed in Materials and Methods. Membranes were reprobed with anti-L1 mAb 5G3 to confirm precipitation of L1. Integrin subunits
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precipitated with L1 appears to be ,1% of the total avail-
able cellular b1. However, since the L1-reactive b1 inte-
grins (i.e., a5b1 and a9b1) constitute only a small fraction
of the total b1 integrin expression by M21-L cells (,10%)
this is not unexpected. Consistent with this, we estimate
that significantly more of the available a5b1 integrin pool
coprecipitated with L1 (z5%). However, such estimates
may be underestimates since it is not clear how stable L1–
integrin complexes are under the detergent conditions
used during the immunoprecipitation.
Discussion
In this study, we have shown that integrin binding to intact
L1 cannot be solely attributed to the RGD motif present
in the sixth Ig-like domain, but rather involves additional
recognition of sequences in the third FN-like domain
(FN3). As such, we describe two novel integrin-binding
motifs located within the putative B-C and C-C9 loops of
the FN3 domain (QVKGHLR827 and GSQRKHSKR845).
Site-directed mutagenesis of key residues within these mo-
tifs confirmed the primary importance of the sequence
GSQRKHSKR845 for both cell adhesion and direct inte-
grin binding to the FN3 domain. Remarkably, the same
dibasic sequences responsible for supporting integrin
binding to this motif (RK841 and KR845) are also shown to
promote the multimerization of the FN3 domain. In this
regard, multimerization of the GSQRKHSKR845 sequence
precedes, and may be required for, interaction with both
avb3 and a5b1 integrins. Importantly, both homomultimer-
ization of, and integrin binding to FN3 is shown to be regu-
lated both by conformational constraints imposed by other
FN-like domains (FN1) and by plasmin-mediated cleavage
within the sequence RK¯HSK¯RH846. Based on our find-
ings, we propose that L1 may have an expanded role in the
regulation of integrin function, especially at the cell–cell
interface, where bridging events appear to allow L1–inte-
grin (a9b1) colocalization.
The large multidomain organization of L1 has permitted
the evolution of domains and domain regions with distinct
functional attributes. A recent model based on the crystal
structure of hemolin suggests that an antiparallel align-
ment involving the first four Ig-like domains of L1 is re-
sponsible for homophilic L1–L1 binding (Su et al., 1998).
Importantly, the same Ig-like domains involved in ho-
mophilic binding may also adopt a tertiary horseshoe con-
figuration because of acute folding and strong interdomain
pairing (Su et al., 1998), suggesting that homophilic L1–L1
binding at the cell surface may be regulated by an equilib-
rium between open/accessible (extended) and closed/inac-
cessible (globular or horseshoe shaped) conformations
within the distal Ig domains.
In this study, we propose that the functional activity of
the FN-like domains of L1 may also be regulated by open
(extended) and closed (globular) conformations. In this
regard, a recent structural analysis of L1 by rotary shadow-
ing and transmission electron microscopy confirmed that
the FN-like repeats do indeed form a tight globular struc-
ture (Drescher et al., 1996). In addition, an antibody di-
rected towards an epitope located between domains FN2
and FN3 mimics the effects of homophilic L1–L1 binding,
promoting neurite outgrowth and signal transduction (Ap-
pel et al., 1995). Based on their findings, the authors sug-
gest that conformational changes resulting from L1 liga-
tion could funnel to this region of L1, a region that may be
conformationally labile and the ultimate site for the induc-
tion of signaling events. Together, these findings are con-
sistent with the paradigm that the FN-like repeats assume
a closed globular conformation and that extrinsic ligation,
by an antibody or by L1 itself, has important functional
consequences by virtue of exposing a region that is essen-
tial for receptor multimerization, integrin recruitment, and
consequent cell signaling.
While we suggest that homophilic ligation can alter the
conformation of the FN-like repeats, thereby exposing the
FN3 domain and promoting integrin recruitment, other
heterophilic interactions may also have a role. In this re-
gard, it is of particular interest that TAG-1/axonin-1, a
neuron-specific CAM, has been shown to promote neurite
extension via a mechanism that requires both an L1-like
molecule and b1 integrins (Felsenfeld et al., 1994). The au-
thors suggest a mechanism involving a direct interaction
between TAG-1 and L1, leading to a concomitant cis-
interaction between L1 and b1 integrin. The result of these
interactions is signaling via both types of receptors,
thereby culminating in neurite extension. A further possi-
bility is that a direct trans-interaction between integrins
and the RGD motif in the Ig6 domain of L1 is sufficient to
funnel a conformational change to the adjacent FN-like
repeats. This type of interaction would facilitate L1 multi-
merization and further integrin recruitment, even when
the interacting cell type fails to express neuron-associated
CAMs.
The concept that the FN3 domain is involved in self-
association is supported by earlier work, which showed that
beads coated with FN-like domains 3–5 of L1 had a strong
tendency to self-associate (Holm et al., 1995). Consistent
with a central role for the FN3 domain in this process, little
or no aggregation was observed with beads coated with
FN-like domains 1 and 2 or 4 and 5. Furthermore, and in
accordance with our finding that the FN1 domain limits
multimerization through FN3, the authors also observed
that beads coated with FN-like domains 1–5 showed little
tendency towards self-association. Our finding that the
FN3 domain can support cell adhesion is also supported in
the literature. Thus, Appel et al. (1993) demonstrated
strong neural cell adhesion to an L1 fragment consisting of
FN-like domains 3–5. In agreement with our findings, little
adhesion was observed on FN-like domains 1 and 2. Again
supporting a negative regulatory function for the FN1 do-
main in this process, the adhesion observed on FN-like do-
mains 1–5 was markedly reduced in comparison to that
evident on FN-like domains 3–5. While the authors sug-
gested that the neuronal adhesion observed was primarily
due to homophilic ligation between cellular L1 and the L1
fragments, they also proposed a role for an unidentified
heterophilic ligand. Based on the findings presented in this
manuscript, neuronal integrins would be likely candidates
for this role.
Based on our findings, we propose that the FN3 domain
is of essential importance for the biological activity of L1.
As a consequence, it is expected that the activity of this
domain will be tightly regulated. While we propose that
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regulating the activity of FN3, we also detail a second
mechanism based on proteolytic cleavage. An important
and unifying property of L1-like proteins is a susceptibility
to posttranslational cleavage, thus, human and mouse L1,
as well as related molecules in the rat and chick, are sensi-
tive to cleavage within the FN3 domain, yielding frag-
ments that have been detected in neural tissue in vivo
(Rathjen and Schachner, 1984; Faissner et al., 1985; Sadoul
et al., 1988; Wolff et al., 1988; Nybroe et al., 1990; Burgoon
et al., 1995). Cleavage within the FN3 domain is due to the
presence of a highly conserved serine protease–sensitive
region that incorporates dibasic arginine/lysine sequences
(Faissner et al., 1985; Sadoul et al., 1988). Significantly, we
have now shown that this same sequence of basic amino
acids is important for FN3 multimerization and integrin
binding. Furthermore, we show that low concentrations of
plasmin will disrupt such interactions, even in the case of
pre-formed complexes, based upon the ability of plasmin
to cleave within the sequence RK¯HSK¯RH (Nayeem et
al., 1999). This suggests that plasmin-mediated proteolysis
of homomultimerized FN3 domains may provide an im-
portant mechanism for regulating initiation and/or inacti-
vation of L1–integrin interactions. Potential regulation of
L1 function by plasmin is of particular interest, given the
extensive overlap of neurological functions that involve
both plasmin and L1 including neurite extension (Lage-
naur and Lemmon, 1987; Seeds et al., 1997), granule cell
migration (Krystosek and Seeds, 1981; Moos et al., 1988),
nerve regeneration (Salles et al., 1990; Jung et al., 1997),
and long-term potentiation in the hippocampus (Luthl et al.,
1994; Mizutani et al., 1996).
The extent to which the FN3 domain promotes either
cis- or trans-integrin interactions remains to be resolved.
Multimerization of L1 in the plane of the cell membrane
via a domain (i.e., FN3) that is in close proximity to the
membrane may favor the recruitment of integrins in a cis-
type of interaction. The demonstration of colocalization
between a9b1 and L1 on individual cells separated from
cell aggregates supports the concept of a cis-interaction. In
this regard, cis-interactions between integrins and other
receptors, including members of the IgSF, are well docu-
mented and are believed to be an important mechanism
for both regulating the activational status of the integrin,
and for the formation of signaling complexes at the cell–
cell or cell–substrate interface (Porter and Hogg, 1998).
While conformational constraints are proposed to regulate
integrin access to the FN3 domain, such constraints are
less likely to limit integrin recognition of the RGD motif
in the Ig6 domain of L1. Thus, Drescher et al. (1996) con-
clude that the RGD motif in human L1 is available for in-
termolecular interactions based both on the high surface
hydrophobicity of the Ig6 domain and the position of the
motif within a loop structure. Based on this, it is conceiv-
able that RGD-dependent integrins can recognize L1
(Ig6) in its resting conformation via a trans-interaction at
the cell–cell interface. Whether such an interaction is suffi-
cient to initiate a conformational change in L1 and further
integrin recruitment via a cis-non-RGD–dependent mech-
anism remains to be determined. It is also unclear whether
recognition of FN3 by integrins involves the typical ligand-
binding pocket or is the result of an interaction with alter-
native sites on either or both of the integrin subunits.
Specificity for a5b1 and a9b1 to the apparent exclusion of
other b1 integrins does, however, suggest the involvement
of the a-subunit.
Changes in L1 conformation and concomitant L1 clus-
tering may also be important for the recruitment of other
heterophilic ligands reported to undergo cis-interactions
with L1. Candidate ligands include the following: CD9
(Schmidt et al., 1996), NCAM (Feizi, 1994), CD24 (Kad-
mon et al., 1995), axonin-1/TAG-1 (Kunz et al., 1998), and
the FGF receptor (FGFr; Viollet and Doherty, 1997). It is
conceivable that L1 clustering results in the recruitment of
a variety of signaling elements (e.g., CD9, CD24, and
FGFr) culminating in the formation of large signaling
complexes at the cell–cell interface. In this regard, it has
been suggested that trans-homophilic L1–L1 ligation leads
to L1 clustering and the recruitment of FGFr (Viollet and
Doherty, 1997). Downstream signaling events resulting
from the activation of the FGF tyrosine kinase receptor
have now been shown to be responsible for L1-mediated
neurite extension (Viollet and Doherty, 1997). The poten-
tial recruitment of CD9 is also of particular interest since
this tetraspan signaling molecule is also known to associ-
ate with certain integrins (Berditchevski and Odintsova,
1999) and could, therefore, serve to stabilize cis-complexes
formed between integrins and L1. Given the pivotal im-
portance of the third FN-like repeat of L1, it may prove
significant that this domain also has been implicated in the
cis-interaction between the chick L1 orthologue NgCAM
and axonin-1/TAG-1 (Kunz et al., 1998). While we specu-
late that changes in L1 conformation and concomitant L1
clustering could result in the recruitment of a variety of
signaling molecules, we do not exclude the possibility that
certain cis-interacting ligands may compete with or inhibit
integrin recruitment or that some heterophilic ligands will
preferentially interact with L1 in its resting conformation.
The integrin a9b1 identified as an L1 binding partner in
this study has a limited tissue distribution that includes ep-
ithelia, muscle, and cells of the myelomonocytic series
(Palmer et al., 1993; Taooka et al., 1999); no expression
has been reported in the nervous system. The a9b1 integrin
is also present on melanoma cells (Smith and Giachelli,
1998) and a variety of carcinoma cell lines (Palmer et al.,
1993), suggesting a potential role in tumor development.
An overlap in expression between L1 and a9b1 is expected
since L1 also has been described on a variety of epithelial
structures (Thor et al., 1987; Debiec et al., 1998; Kujat et al.,
1995), on carcinoma and melanoma cell lines, and on nor-
mal and transformed myelomonocytic cells (Mujoo et al.,
1986; Linnemann et al., 1989; Reid and Hemperly, 1992;
Pancook et al., 1997). Recently, it has been demonstrated
that a9b1 can promote neutrophil transendothelial cell mi-
gration via an interaction with VCAM-1 (Taooka et al.,
1999). L1–a9b1 interactions may also modulate transen-
dothelial cell migration either directly by promoting adhe-
sion to the endothelium or indirectly by modulating the
activity of a9b1 and its ability to bind to VCAM-1. Simi-
larly, the b1-mediated adhesion of eosinophils to endothe-
lial cells has also been shown to be modulated by ligation
of PECAM-1 on endothelial cells (Chiba et al., 1999). In
this regard, L1 has not only been described on my-
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1992; Pancook et al., 1997), but also on activated small ves-
sel endothelium in certain diseases (Felding-Habermann
et al., 1997).
The observation that the integrins identified in this
study are interacting with multimeric FN3 is consistent
with the concept that L1 clustering is important for the re-
cruitment of integrins, and would also explain why a9b1
can only be colocalized with L1 at cell–cell interfaces,
where classical L1–L1 homophilic interactions and conse-
quent clustering would be expected to occur. The concept
that ligand polymerization can potentiate integrin binding
is supported by recent work that demonstrates preferen-
tial integrin-mediated adhesion to multivalent, rather than
monovalent extracellular matrix components in lymphoid
cells (Stupak et al., 1999). Indeed, a primary regulator of
inflammatory cell entry into sites of wounding is the accu-
mulation of polymerized provisional matrix components
including fibrin, fibronectin, and vitronectin (Dvorak et al.,
1995). Although the enhanced affinity of the aforemen-
tioned matrices primarily rely upon appropriate spacing or
exposure of canonical cell adhesion motifs (e.g., RGD), it
is not clear whether the integrin–L1 interactions described
in this report are due to the creation of neorecognition
sites within the complexed ligand, or rather reflect the op-
timal presentation of multiple, appropriately spaced, pre-
viously available, low affinity binding motifs in such a
manner that the clustered motifs stabilize integrin binding
through avidity modulation.
An important implication of the work presented here is
that cell–cell contact and concomitant L1 clustering can
potentiate integrin activation and/or signaling. As a conse-
quence, L1 may directly modulate those processes nor-
mally associated with integrin-binding to the extracellular
matrix, including cell motility, survival, and proliferation.
The fact that avb3 can associate with L1 via interaction
with its RGD motif (Montgomery et al., 1996; Felding-
Habermann et al., 1997; Oleszewski et al., 1999) as well as
via an interaction with the multimerized FN3 domain sug-
gests an interdependent relationship that may have impor-
tant ramifications for cell survival and motility. For exam-
ple, a recent study has shown that avb3 is essential for the
survival of melanoma cells in the dermal microenviron-
ment, however, detailed examination of these cells indi-
cates that they are surviving as cell clusters (Hsu et al.,
1998). In this context cell–cell interaction and concomitant
L1–avb3 ligation may represent an important survival
mechanism. The ability of L1 to induce signaling via its in-
teraction with integrins requires confirmation, however,
the early steps of neurite extension on L1 are dependent
on protein phosphorylation events involving the nonre-
ceptor tyrosine kinase pp60c-src, a known mediator of in-
tegrin signaling (Ignelzi et al., 1994), suggesting that L1 in-
teractions may indeed facilitate signaling in this manner.
The findings reported here significantly extend our cur-
rent knowledge of L1–integrin interactions. We have doc-
umented two novel integrin-binding sequences within pu-
tative loops in the third FN-like domain of L1. One of
these sequences is shown to self-associate, resulting in
both domain multimerization and integrin ligation. To our
knowledge, this is the first report of a spontaneously self-
associating peptide sequence that can also support direct
integrin binding. Dual regulation of FN3-integrin binding
is proposed based on conformational constraints and sen-
sitivity to proteolysis. Based on our observations, and
those of others, we propose a model in which distal trans-
ligation of L1 at the cell–cell interface induces a conforma-
tion change within the L1 ectodomain that culminates in
receptor multimerization and integrin recruitment via the
FN3 domain. The findings presented in this study further
suggest an intimate association between integrins and L1,
an association that may have important implications for
downstream signaling events.
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Note Added in Proof. While this manucript was being reviewed, it was re-
ported that the third fibronectin repeat of L1 is required for L1 to serve as
an optimal substratum for neurite extension. Stallcup, W.B. 2000. J. Neu-
rosci. Res. 61:33–43.
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